Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and NeckTPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck TumorsTreatment Selection According to Skin Reaction to CetuximabGemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal CancerTrial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal CancerImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck CarcinomaReactivating NK Cells in Treating Refractory Head and Neck CancerDurvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCCWindow Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral CavityPredictive Biomarkers for Response to Nivolumab in Head and Neck Squamous Cell CarcinomaNeoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and NeckPersonalized and Cell-based Antitumor Immunization MVX-ONCO-1 in Advanced HNSCCMetronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid TumoursRadiotherapy With Double Checkpoint Blockade of Locally Advanced HNSCCAdjuvant Nivolumab and Lirilumab in Patients With Relapsed, Resectable Squamous Cell Carcinoma of the Head and NeckConcomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck CancerPorfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck CancerFRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/PaclitaxelPhase II Study of Perioperative Immunotherapy in Patients With Advanced Non-Virally Associated Squamous Cell CarcinomaStudy of Nivolumab Alone or in Combination With Ipilimumab as Immunotherapy vs Standard Follow-up in Surgical Resectable HNSCC After Adjuvant TherapySBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck CarcinomaThe Effects of Upper Airway and Digestive Tract Tumors on the Immune SystemRadioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid CancerPhase II Trial of Allovectin-7® for Head and Neck CancerMolecular and Genomic Profiling of Head and Neck TumorsInduction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical TrialPhase I Trial: T4 Immunotherapy of Head and Neck CancerStudy of HPV Specific Immunotherapy in Patients With HPV Associated Head and Neck Squamous Cell CarcinomaStudy of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer PatientsSelection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic TherapiesA Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHNImmunotherapy Study of Evofosfamide in Combination With IpilimumabExpressing Personalized Tumor Antigens StudyEPR Tumor Oximetry With CE India InkStudy of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or MelanomaSBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&NCemiplimab in Treating Participants With Recurrent Stage III-IV Head and Neck Squamous Cell Cancer Before Surgery
P1050
Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic reviewScalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis.Unusual presentations of functional parathyroid cysts: a case series and review of the literature.Characteristics of a Maxillofacial Prosthesis Consultation Within Assistance Publique - Hopitaux de Paris
P921
Q58407432-3C784886-2742-42ED-947B-E5AC7661FEB9Q58407503-60120E78-735E-4A08-81B7-65FB4A9DA282Q58407505-36ED6EE0-19F4-47FD-B669-7F92162E7EFBQ58407521-E0AFA7C2-5DF1-44C5-906F-6DD31A17A7A1Q58407539-DEF2DFE7-5A5F-4A71-A9BF-D160A703ADA3Q58407672-C48E2994-9690-48F6-88C1-3C359B662A25Q58407687-DD3FCA53-7BDC-46E4-ADCE-3CB966FEEBC0Q58407690-419C1B08-EC96-41FD-BFC7-5F13A8CF1C8EQ58407738-E303BBC4-DBB1-4833-9B72-56A978B281EBQ58407750-A9A54B37-9923-46E9-B62C-9C2B8DDF7244Q58407751-34FF0CF0-A91C-4602-BB8B-762A5AF8EBCBQ58407761-FDB78598-C07E-4325-B500-82DBCDDB4D7EQ58407765-4AF7BDDD-8E39-4951-B811-3CBC748A6A4AQ58407796-83655DC4-39CA-4EDE-92B8-C39070D895F1Q58407832-7962B67A-E43B-49FC-8365-49A73A2D094DQ58407840-2146C86E-D131-4A0F-8027-C5A944CCFA83Q58407850-32DF0A0F-1F26-4D8F-B2CA-D8CD69908CDDQ58407861-E55C50E7-9DE6-4A65-AEEB-23A71ACCD02DQ58407864-55EB5BCB-D2C2-44B3-8C35-EFDA1BBFC704Q58407875-B8621B05-02E9-439A-8E28-63984B2FB3E2Q58407894-FD2362E6-4373-448A-AAEB-A721A97D2BDFQ58407896-5891443C-3472-465F-A257-731A510F4575Q58843885-3BA1732B-0428-4779-B540-A6C3C7B0D6E4Q58844184-FEF6D260-94FA-4BC0-BFA5-91BD3C026CA7Q58844253-284BA5D6-FC8F-4070-B70E-82C5EB652E10Q58844341-4EAF6559-0ABB-4F45-9AF9-1B52981F3085Q58844445-E4C503C5-DA79-4C53-A9CB-DEED9EC2F703Q58844910-1D2A6721-64A8-4C30-BDA1-9089F5B2006BQ58845031-98DA3924-5268-4AF6-96CD-D0CE56CB352BQ58845198-2C2CCA3C-134D-4F2A-8862-9CBFF40197F4Q58845444-71D33878-FD67-48F2-A375-6FFEF4A0D418Q58845516-3426A230-E4E0-4E09-8726-A525A4C27AB6Q58846066-65E4C374-84D7-46EF-90F4-7F01B43CCF39Q58846214-1319A05A-94CE-419C-9746-552D01EFD7FDQ58846238-6E92C8DB-21EC-4A33-A9D6-049BFBCDB10AQ58846494-1343A274-9B81-4DA2-B95D-E4558B883499Q58846565-BDAFF9DD-95FE-4F06-A230-D1406FFF8593Q58846601-934031D3-03B6-4C6E-BCF0-5F56531BDF47Q58846772-7E3D5366-494B-422E-830F-86F83D1971B3Q58846958-BD3A33DA-6C7D-49A2-806C-80C283BDDBC6
P1050
Q1783924-23aed945-41cb-3e14-a598-f2f0cbb847d3Q18557904-E124DF09-B68B-4767-A6F0-8ABFF185DF12Q18971468-17fc54b1-4fb8-f3c7-6b34-8a8bc9de8ae8Q18975910-c5307359-4d85-983c-c3dc-8b7046451f43Q18976005-41A4DEA8-3393-433B-B1FB-3760EE45A879Q19000685-157c8d04-4e92-632f-b863-2cd5050c260dQ3267772-7A7E0A20-2BFC-4260-A3E7-F308F7126C18Q55950068-2227576d-41e2-5072-94e8-5839fd381ffeQ56013680-FDDA77DD-586F-4B27-A3E4-3296B8410952
P279
description
Human disease
@en
чалавечае захворваньне
@be-tarask
مرض يصيب الإنسان
@ar
name
head neoplasm
@en
neoplasia de cabeza y cuello
@es
svulst i hovudet
@nn
tumeurs de la tête et du cou
@fr
галаўны нэаплязм
@be-tarask
type
label
head neoplasm
@en
neoplasia de cabeza y cuello
@es
svulst i hovudet
@nn
tumeurs de la tête et du cou
@fr
галаўны нэаплязм
@be-tarask
altLabel
Head and Neck Neoplasm (Excluding Central Nervous System)
@en
Head and Neck Neoplasm
@en
Head and Neck Tumor
@en
Neoplasm of Head and Neck
@en
Neoplasm of the Head and Neck
@en
Tumor of Head and Neck
@en
Tumor of the Head and Neck
@en
craniocervical region neoplasm (disease)
@en
craniocervical region tumor
@en
head and neck neoplasm
@en
prefLabel
head neoplasm
@en
neoplasia de cabeza y cuello
@es
svulst i hovudet
@nn
tumeurs de la tête et du cou
@fr
галаўны нэаплязм
@be-tarask
P279
P527
P486
P672
P1692
P1748
P1995
P2888
P2892
P486
P527
P5270
MONDO:0005586
P672
C04.588.443